T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,150.00
+225.00 (5.73%)
Apr 1, 2025, 3:30 PM KST

T&R Biofab Revenue

T&R Biofab had revenue of 1.10B KRW in the quarter ending September 30, 2024, with 15.08% growth. This brings the company's revenue in the last twelve months to 5.08B, up 3.00% year-over-year. In the year 2023, T&R Biofab had annual revenue of 5.20B, down -9.65%.

Revenue (ttm)
5.08B
Revenue Growth
+3.00%
P/S Ratio
17.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
89.42B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.20B-555.45M-9.65%
Dec 31, 20225.75B2.52B77.90%
Dec 31, 20213.23B-3.57B-52.47%
Dec 31, 20206.81B5.52B428.71%
Dec 31, 20191.29B312.81M32.11%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 66.19T
LG Energy Solution 25.62T
Samsung Biologics 4,547.32B
Hyundai Motor Company 175.23T
Celltrion 3,557.30B
Kia Corporation 107.45T
KB Financial Group 15.01T
Revenue Rankings